In addition, the potential correlation between FAM65A genetic alteration and the prognosis with UCEC, prostate adenocarcinoma (PRAD) and skin cutaneous melanoma (SKCM) is presented in Fig. S3. This evidence concerns the gene RIPOR1 and prostate adenocarcinoma.